Evidence map›Paper›PMID 41522673›Full record

ArticleTremor and other hyperkinetic movements (New York, N.Y.)2026

Proceedings of the 12

Fabrizio Vacca, Binnaz Yalcin, Lars Kaestner, Adrian Danek, Kevin Peikert, Ruth H Walker, Muhammad Ansar

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Tremor and other hyperkinetic movements (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fabrizio VaccaDepartment of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, Lausanne, Switzerland.ORCID 0000-0003-3984-1395
Binnaz YalcinInstitut NeuroMyoGene-PGNM UCBL-CNRS UMR5261 INSERM U1315, Lyon, France.ORCID 0000-0002-1924-6807
Lars KaestnerTheoretical Medicine and Biosciences, Medical Faculty, Saarland University, 66421 Homburg, Germany.ORCID 0000-0001-6796-9535
Adrian DanekNeurologische Klinik und Poliklinik, LMU Klinikum, LMU München, Munich, Germany.ORCID 0000-0001-8857-5383
Kevin PeikertTranslational Neurodegeneration Section "Albrecht Kossel", Department of Neurology, Rostock University Medical Center, University of Rostock, Germany.ORCID 0000-0002-0845-2453
Ruth H WalkerDepartment of Neurology, James J. Peters Veterans Affairs Medical Center, Bronx, NY, USA.ORCID 0000-0002-8366-072X
Muhammad AnsarDepartment of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, Lausanne, Switzerland.ORCID 0000-0001-7299-3185

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 12

Indexed as

Developmental DisabilitiesIntellectual DisabilityMicrocephalyMuscle HypotoniaNeuroacanthocytosisVesicular Transport ProteinsFingersHumansMyopiaObesityRetinal DegenerationVesicular Transport ProteinsVPS13A protein, humanbridge-likeCohen syndromelipid transfer proteninsMcLeod syndromeNeuroacanthocytosisXK-disease

Identifiers

PMID41522673
PMCPMC12785667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.